Cargando…
Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
OBJECTIVES: This study aimed to determine the in vitro susceptibility of commonly encountered Gram-negative bacilli (GNB) recovered from patients admitted to intensive care units (ICUs) in Taiwan against colistin, carbapenems, and other comparative agents. METHODS: In total, 758 nonduplicate GNB iso...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421902/ https://www.ncbi.nlm.nih.gov/pubmed/30936726 http://dx.doi.org/10.2147/IDR.S194482 |
_version_ | 1783404317509681152 |
---|---|
author | Lai, Chih-Cheng Chen, Ying-Sheng Lee, Nan-Yao Tang, Hung-Jen Lee, Susan Shin-Jung Lin, Chin-Fu Lu, Po-Liang Wu, Jiunn-Jong Ko, Wen-Chien Lee, Wen-Sen Hsueh, Po-Ren |
author_facet | Lai, Chih-Cheng Chen, Ying-Sheng Lee, Nan-Yao Tang, Hung-Jen Lee, Susan Shin-Jung Lin, Chin-Fu Lu, Po-Liang Wu, Jiunn-Jong Ko, Wen-Chien Lee, Wen-Sen Hsueh, Po-Ren |
author_sort | Lai, Chih-Cheng |
collection | PubMed |
description | OBJECTIVES: This study aimed to determine the in vitro susceptibility of commonly encountered Gram-negative bacilli (GNB) recovered from patients admitted to intensive care units (ICUs) in Taiwan against colistin, carbapenems, and other comparative agents. METHODS: In total, 758 nonduplicate GNB isolates were obtained from clinical specimens of ICU patients at seven medical centers in 2016. Minimum inhibitory concentrations (MICs) were determined using the Vitek 2 susceptibility system. The reference broth-microdilution method was performed to determine MICs of colistin. Five main carbapenemase genes among carbapenem-non-susceptible GNB and mcr-1–mcr5 genes among colistin non-wild-type or -resistant isolates were determined. RESULTS: After exclusion 38 Proteus mirabilis and 13 Morganella morganii spp. among 361 Enterobacteriaceae isolates, 34 (9.4%) isolates were carbapenem-insusceptible, 91.1% (n=31) were colistin wild type, and three and one Klebsiella pneumoniae isolates carried bla(KPC) and bla(OXA48)-like, respectively. Carbapenem-insusceptible isolates were found in 23.4% (30 of 128) and 63.0% (87 of 138) of isolates of the Pseudomonas aeruginosa and Acinetobacter baumannii complex, respectively. mcr-1 was detected in two (1.8%) Enterobacter cloacae isolates. Very major errors between two methods of susceptibility to colistin were found in 1.5% of K. pneumoniae, 27.5% of E. cloacae, 4.7% of P. aeruginosa, and 10.1% of A. baumannii complex isolates. CONCLUSION: In this study, 8.7% of Enterobacteriaceae isolates from ICUs were not susceptible to carbapenem, and bla(KPC) and bla(OXA48)-like were found among three and one carbapenem-insusceptible K. pneumoniae isolates, respectively. Colistin MICs determined by Vitek 2 were not reliable, especially for E. cloacae and A. baumannii complex isolates. |
format | Online Article Text |
id | pubmed-6421902 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-64219022019-04-01 Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) Lai, Chih-Cheng Chen, Ying-Sheng Lee, Nan-Yao Tang, Hung-Jen Lee, Susan Shin-Jung Lin, Chin-Fu Lu, Po-Liang Wu, Jiunn-Jong Ko, Wen-Chien Lee, Wen-Sen Hsueh, Po-Ren Infect Drug Resist Clinical Trial Report OBJECTIVES: This study aimed to determine the in vitro susceptibility of commonly encountered Gram-negative bacilli (GNB) recovered from patients admitted to intensive care units (ICUs) in Taiwan against colistin, carbapenems, and other comparative agents. METHODS: In total, 758 nonduplicate GNB isolates were obtained from clinical specimens of ICU patients at seven medical centers in 2016. Minimum inhibitory concentrations (MICs) were determined using the Vitek 2 susceptibility system. The reference broth-microdilution method was performed to determine MICs of colistin. Five main carbapenemase genes among carbapenem-non-susceptible GNB and mcr-1–mcr5 genes among colistin non-wild-type or -resistant isolates were determined. RESULTS: After exclusion 38 Proteus mirabilis and 13 Morganella morganii spp. among 361 Enterobacteriaceae isolates, 34 (9.4%) isolates were carbapenem-insusceptible, 91.1% (n=31) were colistin wild type, and three and one Klebsiella pneumoniae isolates carried bla(KPC) and bla(OXA48)-like, respectively. Carbapenem-insusceptible isolates were found in 23.4% (30 of 128) and 63.0% (87 of 138) of isolates of the Pseudomonas aeruginosa and Acinetobacter baumannii complex, respectively. mcr-1 was detected in two (1.8%) Enterobacter cloacae isolates. Very major errors between two methods of susceptibility to colistin were found in 1.5% of K. pneumoniae, 27.5% of E. cloacae, 4.7% of P. aeruginosa, and 10.1% of A. baumannii complex isolates. CONCLUSION: In this study, 8.7% of Enterobacteriaceae isolates from ICUs were not susceptible to carbapenem, and bla(KPC) and bla(OXA48)-like were found among three and one carbapenem-insusceptible K. pneumoniae isolates, respectively. Colistin MICs determined by Vitek 2 were not reliable, especially for E. cloacae and A. baumannii complex isolates. Dove Medical Press 2019-03-14 /pmc/articles/PMC6421902/ /pubmed/30936726 http://dx.doi.org/10.2147/IDR.S194482 Text en © 2019 Lai et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Clinical Trial Report Lai, Chih-Cheng Chen, Ying-Sheng Lee, Nan-Yao Tang, Hung-Jen Lee, Susan Shin-Jung Lin, Chin-Fu Lu, Po-Liang Wu, Jiunn-Jong Ko, Wen-Chien Lee, Wen-Sen Hsueh, Po-Ren Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) |
title | Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) |
title_full | Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) |
title_fullStr | Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) |
title_full_unstemmed | Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) |
title_short | Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) |
title_sort | susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from surveillance of multicenter antimicrobial resistance in taiwan (smart) |
topic | Clinical Trial Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421902/ https://www.ncbi.nlm.nih.gov/pubmed/30936726 http://dx.doi.org/10.2147/IDR.S194482 |
work_keys_str_mv | AT laichihcheng susceptibilityratesofclinicallyimportantbacteriacollectedfromintensivecareunitsagainstcolistincarbapenemsandothercomparativeagentsresultsfromsurveillanceofmulticenterantimicrobialresistanceintaiwansmart AT chenyingsheng susceptibilityratesofclinicallyimportantbacteriacollectedfromintensivecareunitsagainstcolistincarbapenemsandothercomparativeagentsresultsfromsurveillanceofmulticenterantimicrobialresistanceintaiwansmart AT leenanyao susceptibilityratesofclinicallyimportantbacteriacollectedfromintensivecareunitsagainstcolistincarbapenemsandothercomparativeagentsresultsfromsurveillanceofmulticenterantimicrobialresistanceintaiwansmart AT tanghungjen susceptibilityratesofclinicallyimportantbacteriacollectedfromintensivecareunitsagainstcolistincarbapenemsandothercomparativeagentsresultsfromsurveillanceofmulticenterantimicrobialresistanceintaiwansmart AT leesusanshinjung susceptibilityratesofclinicallyimportantbacteriacollectedfromintensivecareunitsagainstcolistincarbapenemsandothercomparativeagentsresultsfromsurveillanceofmulticenterantimicrobialresistanceintaiwansmart AT linchinfu susceptibilityratesofclinicallyimportantbacteriacollectedfromintensivecareunitsagainstcolistincarbapenemsandothercomparativeagentsresultsfromsurveillanceofmulticenterantimicrobialresistanceintaiwansmart AT lupoliang susceptibilityratesofclinicallyimportantbacteriacollectedfromintensivecareunitsagainstcolistincarbapenemsandothercomparativeagentsresultsfromsurveillanceofmulticenterantimicrobialresistanceintaiwansmart AT wujiunnjong susceptibilityratesofclinicallyimportantbacteriacollectedfromintensivecareunitsagainstcolistincarbapenemsandothercomparativeagentsresultsfromsurveillanceofmulticenterantimicrobialresistanceintaiwansmart AT kowenchien susceptibilityratesofclinicallyimportantbacteriacollectedfromintensivecareunitsagainstcolistincarbapenemsandothercomparativeagentsresultsfromsurveillanceofmulticenterantimicrobialresistanceintaiwansmart AT leewensen susceptibilityratesofclinicallyimportantbacteriacollectedfromintensivecareunitsagainstcolistincarbapenemsandothercomparativeagentsresultsfromsurveillanceofmulticenterantimicrobialresistanceintaiwansmart AT hsuehporen susceptibilityratesofclinicallyimportantbacteriacollectedfromintensivecareunitsagainstcolistincarbapenemsandothercomparativeagentsresultsfromsurveillanceofmulticenterantimicrobialresistanceintaiwansmart |